<DOC>
	<DOCNO>NCT00687245</DOCNO>
	<brief_summary>The purpose study determine area plasma concentration-time curve ( AUC ) esomeprazole single oral dos 5 mg , 10 mg 20 mg esomeprazole pediatric patient 1 11 years-old inclusive endoscopically-proven GERD .</brief_summary>
	<brief_title>Pharmacokinetic Study Esomeprazole Magnesium Patients 1 11 Years-Old With Endoscopically-Proven Gastroesophageal Reflux Disease ( GERD )</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Patients must able take solid bland food ( eg , applesauce ) . Patients must weigh least 8 kg investigator 's discretion able undergo extraction adequate volume blood . The patient 's weight height percentile less 90th percentile and/or BMI must 5th 85th percentile age . Patients must diagnose endoscopicallyproven GERD Use investigational compound participation another clinical trial within 28 day prior screen visit . History presence gastrointestinal , hepatic renal disease condition could interfere absorption , distribution , metabolism excretion esomeprazole . Unstable diabetes mellitus history seizure disorder . Any acute chronic illness medical history , opinion investigator and/or sponsor , could compromise patient 's safety successful participation study .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>child</keyword>
	<keyword>reflux</keyword>
	<keyword>GERD</keyword>
	<keyword>pediatric</keyword>
</DOC>